Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Milestone Pharmaceuticals Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +4 vs. Q4 2023
- Shares held
- 31.3M
- +13.6M (+76.2%) vs. Q4 2023
- Total value
- $56.4M
- +$26.7M (+89.9%) vs. Q4 2023
- New holders
- 11
- 13 more added
- Sold out
- 7
- 7 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 4,971,344 | $8.90M | 0.00% | +1,700,595+52.0% | Added |
| RTW Investments, LP | 3,256,102 | $5.83M | 0.09% | 00.0% | Unchanged |
| Millennium Management LLC | 2,855,612 | $5.11M | 0.00% | +1,361,123+91.1% | Added |
| Alta Fundamental Advisers LLC | 2,371,289 | $4.24M | 2.12% | +700,000+41.9% | Added |
| Lion Point Capital, LP | 2,300,207 | $4.12M | 7.87% | +650,000+39.4% | Added |
| Citadel Advisors LLC | 2,272,404 | $4.07M | 0.00% | +2,037,499+867.4% | Added |
| OrbiMed Advisors LLC | 2,000,000 | $3.58M | 0.07% | +2,000,000 | New |
| Nantahala Capital Management, LLC | 1,750,000 | $3.13M | 0.31% | +1,750,000 | New |
| Stonepine Capital Management, LLC | 1,462,296 | $2.62M | 2.08% | +1,462,296 | New |
| Goldman Sachs Group Inc | 1,353,067 | $2.42M | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 1,326,085 | $2.37M | 0.59% | 00.0% | Unchanged |
| Altium Capital Management LP | 1,212,882 | $2.17M | 0.97% | +1,212,882 | New |
| Morgan Stanley | 819,828 | $1.47M | 0.00% | +130,428+18.9% | Added |
| Velan Capital Investment Management LP | 650,000 | $1.16M | 0.63% | +650,000 | New |
| BML Capital Management, LLC | 606,145 | $1.08M | 0.73% | +163,793+37.0% | Added |
| Monashee Investment Management LLC | 500,000 | $895.0K | 0.11% | +500,000 | New |
| Ikarian Capital, LLC | 466,019 | $834.2K | 0.23% | +3,191+0.7% | Added |
| Bank of Montreal | 273,100 | $786.5K | 0.00% | +273,100 | New |
| Boxer Capital, LLC | 309,007 | $553.1K | 0.03% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 202,460 | $362.4K | 0.10% | +202,460 | New |
| Ancora Advisors, LLC | 60,000 | $107.4K | 0.00% | +10,000+20.0% | Added |
| Envestnet Asset Management Inc | 51,833 | $92.8K | 0.00% | +31,163+150.8% | Added |
| Dimensional Fund Advisors LP | 39,450 | $70.6K | 0.00% | −34,254−46.5% | Reduced |
| Boothbay Fund Management, LLC | 30,779 | $55.1K | 0.00% | +3,191+11.6% | Added |
| Northern Trust Corp | 28,316 | $50.7K | 0.00% | −3,654−11.4% | Reduced |
| Clear Creek Financial Management, LLC | 25,000 | $44.8K | 0.01% | −6,750−21.3% | Reduced |
| State Street Corp | 18,923 | $33.9K | 0.00% | −2,688−12.4% | Reduced |
| Geode Capital Management, LLC | 17,576 | $31.5K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 17,427 | $31.2K | 0.00% | +17,427 | New |
| BNP Paribas Arbitrage, SA | 16,900 | $30.3K | 0.00% | +10,800+177.0% | Added |
| Beta Wealth Group, Inc. | 14,127 | $25.3K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 13,403 | $24.0K | 0.00% | +13,403 | New |
| Creative Planning | 13,080 | $23.4K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 10,500 | $18.8K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 7,100 | $11.9K | 0.00% | +3,250+84.4% | Added |
| Advisor Group Holdings, Inc. | 6,000 | $10.7K | 0.00% | −8,054−57.3% | Reduced |
| UBS Group AG | 2,618 | $4.69K | 0.00% | +2,618 | New |
| ICA Group Wealth Management, LLC | 200 | $358 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 194 | $347 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $179 | 0.00% | −255,085−100.0% | Reduced |
| Oliver Lagore Vanvalin Investment Group | 100 | $179 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 478 | $0 | 0.00% | −608−56.0% | Reduced |
| VR Adviser, LLC | 0 | $0 | 0.00% | −925,048−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −20,762−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,686−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,299−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,135−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10,662−100.0% | Sold out |
| PVG Asset Management Corp | – | – | – | – | Not filed |